Creaque C Tyler, Aireona C Armagon, Ildebrando E Garcia, Angie Eaton
{"title":"A Review of Therapeutics for the Treatment of Lupus.","authors":"Creaque C Tyler, Aireona C Armagon, Ildebrando E Garcia, Angie Eaton","doi":"10.4140/TCP.n.2025.135","DOIUrl":null,"url":null,"abstract":"<p><p>Lupus treatment recently saw the approval of new drugs after a 12-year gap since the last approval of belimumab (Benlysta) in 2011. This article reviews these newly FDA-approved agents, which have demonstrated efficacy and safety in the management of systemic lupus erythematosus and lupus nephritis, a severe complication of the disease.</p>","PeriodicalId":41635,"journal":{"name":"Senior Care Pharmacist","volume":"40 3","pages":"135-144"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Senior Care Pharmacist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2025.135","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
A Review of Therapeutics for the Treatment of Lupus.
Lupus treatment recently saw the approval of new drugs after a 12-year gap since the last approval of belimumab (Benlysta) in 2011. This article reviews these newly FDA-approved agents, which have demonstrated efficacy and safety in the management of systemic lupus erythematosus and lupus nephritis, a severe complication of the disease.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
